XML 29 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Balance Sheet Components
12 Months Ended
Dec. 31, 2020
Balance Sheet Components  
Balance Sheet Components

6. Balance Sheet Components

Inventory

Inventory at December 31, 2020 and 2019 consisted of the following:

 

 

 

 

 

 

 

 

 

December 31,

(in thousands)

    

2020

    

2019

Raw Material

 

$

1,321

 

$

457

Work in Process

 

 

1,026

 

 

1,211

Finished Goods

 

 

435

 

 

461

Inventory

 

$

2,782

 

$

2,129

 

Property and Equipment, net

Property and equipment at December 31, 2020 and 2019 consisted of the following:

 

 

 

 

 

 

 

 

 

December 31,

(in thousands)

    

2020

    

2019

Land

 

$

396

 

$

396

Lab equipment

 

 

418

 

 

411

Clinical equipment

 

 

65

 

 

65

Software

 

 

63

 

 

63

Total property and equipment at cost

 

 

942

 

 

935

Accumulated depreciation

 

 

(265)

 

 

(225)

Property and equipment, net

 

$

677

 

$

710

 

Depreciation and amortization expense was $40,000 and $50,000 for the years ended December 31, 2020 and 2019, respectively.  

Intangible assets, net

Intangible assets, net of amortization, at December 31, 2020 and 2019 consisted of the following:

 

 

 

 

 

 

 

 

 

December 31,

(in thousands)

    

2020

    

2019

Developed technology

 

$

25,000

 

$

25,000

Accumulated developed technology amortization

 

 

(5,694)

 

 

(4,028)

Developed technology, net

 

 

19,306

 

 

20,972

In-process research and development

 

 

4,800

 

 

8,800

Impairment

 

 

—  

 

 

(4,000)

In process research and development, net

 

 

4,800

 

 

4,800

Trademarks

 

 

300

 

 

300

Accumulated trademark amortization

 

 

(69)

 

 

(48)

Trademarks, net

 

 

231

 

 

252

Total intangible assets, net

 

$

24,337

 

$

26,024

 

In June 2019, the Company determined that in-process research and development was impaired and recorded an impairment loss of $4.0 million in the consolidated statement of operations for the year ended December 31, 2019. Amortization expense of finite-lived intangibles was $1.7 million for the years ended December 31, 2020 and 2019.

The following table summarizes the Company’s estimated future amortization expense of intangible assets with finite lives as of December 31, 2020:

 

 

 

 

(in thousands)

    

Amounts

2021

 

$

1,687

2022

 

 

1,687

2023

 

 

1,687

2024

 

 

1,687

2025

 

 

1,687

Thereafter

 

 

11,102

 

 

$

19,537

 

Accrued Liabilities

Accrued liabilities at December 31, 2020 and 2019 consisted of the following:

 

 

 

 

 

 

 

 

    

December 31,

(in thousands)

    

2020

 

2019

Accrued vacation

 

$

277

 

$

273

Accrued payroll and commission

 

 

43

 

 

111

Accrued payroll tax

 

 

57

 

 

52

Accrued interest

 

 

696

 

 

357

Accrued consulting

 

 

31

 

 

257

Accrued distributor services fees

 

 

1,314

 

 

227

Accrued legal costs

 

 

291

 

 

292

Accrued audit and tax services

 

 

70

 

 

189

Accrued chargebacks and discounts

 

 

736

 

 

337

Accrued other

 

 

978

 

 

827

Total

 

$

4,493

 

$

2,922